Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 3
2002 5
2003 3
2004 1
2005 2
2006 2
2007 1
2009 2
2010 2
2011 1
2012 4
2014 2
2015 2
2016 3
2017 1
2018 5
2019 1
2020 5
2021 7
2022 2
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Current challenges in HER2-positive breast cancer.
Puglisi F, Fontanella C, Amoroso V, Bianchi GV, Bisagni G, Falci C, Fontana A, Generali D, Gianni L, Grassadonia A, Moscetti L, Portarena I, Rossi E, Marchetti P. Puglisi F, et al. Among authors: portarena i. Crit Rev Oncol Hematol. 2016 Feb;98:211-21. doi: 10.1016/j.critrevonc.2015.10.016. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26638862 Free article. Review.
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.
Melaiu O, Vanni G, Portarena I, Pistolese CA, Anemona L, Pomella S, Bei R, Buonomo OC, Roselli M, Mauriello A, Barillari G. Melaiu O, et al. Among authors: portarena i. Int J Mol Sci. 2023 Feb 6;24(4):3226. doi: 10.3390/ijms24043226. Int J Mol Sci. 2023. PMID: 36834641 Free PMC article. Review.
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
Roberto M, Astone A, Botticelli A, Carbognin L, Cassano A, D'Auria G, Fabbri A, Fabi A, Gamucci T, Krasniqi E, Minelli M, Orlandi A, Pantano F, Paris I, Pizzuti L, Portarena I, Salesi N, Scagnoli S, Scavina P, Tonini G, Vici P, Marchetti P. Roberto M, et al. Among authors: portarena i. Cancers (Basel). 2021 Jan 18;13(2):332. doi: 10.3390/cancers13020332. Cancers (Basel). 2021. PMID: 33477469 Free PMC article. Review.
Anxiety and Fear of Breast Cancer Patients During and After the COVID-19 Era.
Vanni G, Materazzo M, Pellicciaro M, Caspi J, Portarena I, Tacconi F, Noce A, Marsella VE, Granai AV, Pistolese CA, Buonomo OC. Vanni G, et al. Among authors: portarena i. Anticancer Res. 2023 Jul;43(7):3255-3263. doi: 10.21873/anticanres.16500. Anticancer Res. 2023. PMID: 37351959
Surgical Treatments for Ductal Carcinoma In Situ (DCIS) in Elderly Patients.
Buonomo OC, Pellicciaro M, Materazzo M, Berardi S, Gigliotti PE, Caspi J, Meucci R, Perretta T, Portarena I, Dauri M, Pistolese CA, Vanni G. Buonomo OC, et al. Among authors: portarena i. Anticancer Res. 2023 Apr;43(4):1555-1562. doi: 10.21873/anticanres.16305. Anticancer Res. 2023. PMID: 36974780
57 results